Sign in

CIK 0001157601

  • Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 5 Insider Annual Insider Trading Report
  6. 5 Insider Annual Insider Trading Report
  7. 3 Insider Initial Statement of Ownership
  8. 4 Grant or award SVP, Corporate Development acquired 25,000 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market buy President and CEO bought 20,000 shares at $3.75 ($75,000)
  11. 4 Open-market buy Director bought 13,333 shares at $3.75 ($49,999)
  12. 4 Open-market buy Director bought 150,000 shares at $3.75 ($562,500)
  13. 4 Open-market buy Director bought 5,000,000 shares at $3.75 ($18,750,000)
  14. 4 Grant or award Director acquired 4,000 shares (grant or award)
  15. 4 Grant or award Director acquired 10,000 shares (grant or award)
  16. 4 Grant or award Director acquired 16,000 shares (grant or award)
  17. 4 Grant or award Director acquired 2,000 shares (grant or award)
  18. 4 Grant or award Director acquired 8,000 shares (grant or award)
  19. 4 Open-market buy Director bought 150,000 shares at $4.71 ($706,515)
  20. 4 Open-market buy President and CEO bought 10,000 shares at $5.03 ($50,299)

Page 18 of 29 · 564 filings